These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15602126)

  • 1. Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy.
    Tolomeo M; Mancuso S; Todaro M; Stassi G; Catalano M; Arista S; Cannizzo G; Barbusca E; Abbadessa V
    J Clin Pathol; 2003 Feb; 56(2):147-51. PubMed ID: 12560398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
    Kirmse B; Hobbs C; Aaron L; Montepiedra G; Summar M; Williams PL; Smith CJ; Van Dyke R; Yu C; Ryckman KK; Borkowsky W;
    Pediatr Infect Dis J; 2022 Aug; 41(8):e306-e311. PubMed ID: 35622436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of machine learning techniques for classification of HIV patients with antiretroviral therapy-induced mitochondrial toxicity from those without mitochondrial toxicity.
    Lee JS; Paintsil E; Gopalakrishnan V; Ghebremichael M
    BMC Med Res Methodol; 2019 Nov; 19(1):216. PubMed ID: 31775643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial changes associated with viral infectious diseases in the paediatric population.
    Romero-Cordero S; Noguera-Julian A; Cardellach F; Fortuny C; Morén C
    Rev Med Virol; 2021 Nov; 31(6):e2232. PubMed ID: 33792105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a 2-Year Supervised Exercise Program Upon the Body Composition and Muscular Performance of HIV-Infected Patients.
    Paes Lda S; Borges JP; Dos Santos FM; de Oliveira TP; Dupin JG; Harris EA; Farinatti P
    Open AIDS J; 2015; 9():80-8. PubMed ID: 26587076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy.
    Ramírez-Marrero FA; Santana-Bagur JL; Joyner MJ; Rodríguez-Zayas J; Frontera W
    P R Health Sci J; 2014 Dec; 33(4):163-9. PubMed ID: 25563033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance.
    Oursler KK; Katzel LI; Smith BA; Scott WB; Russ DW; Sorkin JD
    J Am Geriatr Soc; 2009 Nov; 57(11):2055-61. PubMed ID: 19793156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy.
    Hendrickson SL; Kingsley LA; Ruiz-Pesini E; Poole JC; Jacobson LP; Palella FJ; Bream JH; Wallace DC; O'Brien SJ
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):111-6. PubMed ID: 19339895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.
    Golomb BA; Evans MA
    Am J Cardiovasc Drugs; 2008; 8(6):373-418. PubMed ID: 19159124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA haplogroups influence AIDS progression.
    Hendrickson SL; Hutcheson HB; Ruiz-Pesini E; Poole JC; Lautenberger J; Sezgin E; Kingsley L; Goedert JJ; Vlahov D; Donfield S; Wallace DC; O'Brien SJ
    AIDS; 2008 Nov; 22(18):2429-39. PubMed ID: 19005266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.
    Effros RB; Fletcher CV; Gebo K; Halter JB; Hazzard WR; Horne FM; Huebner RE; Janoff EN; Justice AC; Kuritzkes D; Nayfield SG; Plaeger SF; Schmader KE; Ashworth JR; Campanelli C; Clayton CP; Rada B; Woolard NF; High KP
    Clin Infect Dis; 2008 Aug; 47(4):542-53. PubMed ID: 18627268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.
    Carr A; Miller J; Law M; Cooper DA
    AIDS; 2000 Feb; 14(3):F25-32. PubMed ID: 10716495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
    Dieterich DT
    AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
    Claessens YE; Chiche JD; Mira JP; Cariou A
    Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents.
    Chapplain JM; Beillot J; Begue JM; Souala F; Bouvier C; Arvieux C; Tattevin P; Dupont M; Chapon F; Duvauferrier R; Hespel JP; Rochcongar P; Michelet C
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1477-88. PubMed ID: 15602126
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.